Aromatic Amines and Biomarkers of Human Exposure
暂无分享,去创建一个
[1] P Vineis,et al. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[2] B. Green,et al. Carcinogen–DNA adducts in human breast epithelial cells , 2002, Environmental and molecular mutagenesis.
[3] G. Talaska,et al. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[4] G. Talaska,et al. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography. , 1990, Carcinogenesis.
[5] S. Tannenbaum,et al. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. , 1987, Cancer research.
[6] H. Vainio. Use of biomarkers--new frontiers in occupational toxicology and epidemiology. , 1998, Toxicology letters.
[7] N. van Zandwijk,et al. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] F. Violante,et al. Micronuclei frequencies in hospital workers occupationally exposed to low levels of ionizing radiation: influence of smoking status and other factors. , 2002, Mutagenesis.
[9] P. Vineis,et al. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. , 1990, Journal of the National Cancer Institute.
[10] P. Vineis,et al. 32P-postlabelling analysis of DNA adducted with urinary mutagens from smokers of black tobacco. , 1990, Carcinogenesis.
[11] F. Kadlubar,et al. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. , 1995, Toxicology letters.
[12] D. Warshawsky,et al. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels. , 2001, Biochemical and biophysical research communications.
[13] Mario Medvedovic,et al. 4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice. , 2003, Journal of the National Cancer Institute.
[14] P. Vineis,et al. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. , 2002, Carcinogenesis.
[15] H. K. Wilson,et al. Methylene bis (2-chloroaniline) (MbOCA): towards a biological monitoring guidance value. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[16] F. Massey,et al. Introduction to Statistical Analysis , 1970 .
[17] Arul M Chinnaiyan,et al. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. , 2003, Journal of the National Cancer Institute.
[18] F. Jongeneelen,et al. Reduction of urinary 1-hydroxypyrene excretion in coke-oven workers exposed to polycyclic aromatic hydrocarbons due to improved hygienic skin protective measures. , 1994, The Annals of occupational hygiene.
[19] S. Garte,et al. Metabolic susceptibility genes as cancer risk factors: time for a reassessment? , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[20] B. Henderson,et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.
[21] E. Mark,et al. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. , 1995, Cancer research.
[22] R. Bos,et al. Urothelial cell DNA adducts in rubber workers † , 2002, Environmental and molecular mutagenesis.
[23] P. Vineis,et al. DNA adducts in urothelial cells: Relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke , 1996, International journal of cancer.
[24] S. Tannenbaum,et al. Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking. , 1990, Cancer research.
[25] E. Ward,et al. A Biological Monitoring Method for o-Toluidine and Aniline in Urine Using High Performance Liquid Chromatography with Electrochemical Detection , 1995 .
[26] M. Yao,et al. Monitoring human risk and exposure to trinitrotoluene (TNT) using haemoglobin adducts as biomarkers. , 1995, Toxicology letters.
[27] M. Ciotti,et al. Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. , 1999, Carcinogenesis.
[28] P. Vineis,et al. 4‐aminobiphenyl‐DNA adducts and p53 mutations in bladder cancer , 1998, International journal of cancer.
[29] M. Butler,et al. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. , 1989, Cancer research.
[30] D. Anderson. Factors contributing to biomarker responses in exposed workers. , 1999, Mutation research.
[31] J. Pawliszyn,et al. Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk. , 1999, Chemical research in toxicology.
[32] P. Vineis,et al. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Pawliszyn,et al. Solid-phase microextraction of monocyclic aromatic amines from biological fluids. , 1998, Analytical chemistry.
[34] B. Brunekreef,et al. Dermal Exposure, Handwashing, and Hand Dermatitis in the Rubber Manufacturing Industry , 2001, Epidemiology.
[35] Peter E Barker,et al. Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST). , 2003, Annals of the New York Academy of Sciences.
[36] L. Lowry,et al. Urinary 4,4′-Methylenebis (2-Chloroaniline) (MBOCA): A Case for Biological Monitoring , 1992 .
[37] D. Phillips,et al. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. , 2000, Cancer research.
[38] H. Bartsch,et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[39] A. Osorio,et al. 4,4'-Methylene-bis(2-chloroaniline)-DNA adduct analysis in human exfoliated urothelial cells by 32P-postlabeling. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[40] G. Curigliano,et al. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. , 1996, Carcinogenesis.
[41] R. Sram. Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects. , 1998, Environmental health perspectives.
[42] P. Vineis,et al. Aromatic amines and cancer , 1997, Cancer Causes & Control.
[43] M. Butler,et al. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. , 1991, Cancer research.
[44] H. Bartsch,et al. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. , 1994, Environmental health perspectives.
[45] Yu-jing Zhang,et al. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[46] G. Talaska. Aromatic Amines and Human Urinary Bladder Cancer: Exposure Sources and Epidemiology , 2003, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[47] A. R. Srinivasan,et al. Influence of the carcinogen 4-aminobiphenyl on DNA conformation. , 1985, Carcinogenesis.
[48] R. Hoover,et al. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls. , 1991, Cancer research.
[49] P. Ducos,et al. Assessment of occupational exposure to 4,4′-methylene-bis-(2-chloroaniline) “MOCA” by a new sensitive method for biological monitoring , 1985, International archives of occupational and environmental health.
[50] M. Riffelmann,et al. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons , 1996, International archives of occupational and environmental health.
[51] R. Hayes,et al. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[52] J. Miller,et al. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.
[53] G. Talaska,et al. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. , 1996, Journal of the National Cancer Institute.
[54] F. Jongeneelen,et al. Biological exposure limit for occupational exposure to coal tar pitch volatiles at cokeovens , 1992, International archives of occupational and environmental health.
[55] G. Sabbioni,et al. Hemoglobin binding of bicyclic aromatic amines. , 1998, Chemical research in toxicology.
[56] H. Vainio,et al. Use of biomarkers in risk assessment. , 2001, International journal of hygiene and environmental health.
[57] D W Nebert,et al. Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[58] R. Hayes,et al. Benzidine-DNA adduct levels in human peripheral white blood cells significantly correlate with levels in exfoliated urothelial cells. , 1997, Mutation research.
[59] W. Rom,et al. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. , 2002, Carcinogenesis.
[60] F. Kadlubar. DNA adducts of carcinogenic aromatic amines. , 1994, IARC scientific publications.
[61] R. Hayes,et al. Determination of benzidine, N-acetylbenzidine, and N,N'-diacetylbenzidine in human urine by capillary gas chromatography/negative ion chemical ionization mass spectrometry. , 1996, Analytical biochemistry.
[62] E. W. Mood,et al. Public Health and Preventive Medicine , 1902, Edinburgh Medical Journal.
[63] D. Schrenk,et al. Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex. , 1994, Carcinogenesis.
[64] F. Beland,et al. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. , 1992, Chemical research in toxicology.
[65] L. Ehrenberg,et al. Characterization of hemoglobin adducts from a 4, 4'-methylenedianiline metabolite evidently produced by peroxidative oxidation in vivo. , 1998, Chemical research in toxicology.
[66] N. Probst-Hensch,et al. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[67] Peter E. Barker,et al. Cancer Biomarker Validation: Standards and Process , 2003 .
[68] D. Segerbäck,et al. 32P-postlabelling analysis of DNA adducts of 4,4'-methylenebis(2-chloroaniline) in target and nontarget tissues in the dog and their implications for human risk assessment. , 1993, Carcinogenesis.
[69] A. Tates,et al. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl. , 1990, Carcinogenesis.
[70] F. Beland,et al. DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. , 1995, Carcinogenesis.
[71] P. Vineis,et al. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[72] V. Lakshmi,et al. N-glucuronidation of benzidine and its metabolites. Role in bladder cancer. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[73] G. Talaska,et al. The correlation between DNA adducts and chromosomal aberrations in the target organ of benzidine exposed, partially-hepatectomized mice. , 1987, Carcinogenesis.
[74] S. Selinski,et al. Biological monitoring in workers in a nitrobenzene reduction plant: haemoglobin versus serum albumin adducts , 2001, International Archives of Occupational and Environmental Health.
[75] Milton J. Rosenau,et al. Public Health and Preventive Medicine , 1955 .
[76] S. Schwartz,et al. Issues in the epidemiological analysis and interpretation of intermediate biomarkers. , 2003, Cancer Epidemiology, Biomarkers and Prevention.
[77] R. Hayes,et al. Urinary mutagenicity as a biomarker in workers exposed to benzidine: correlation with urinary metabolites and urothelial DNA adducts. , 1997, Carcinogenesis.
[78] P. Vineis,et al. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. , 1990, Cancer research.
[79] F. Guengerich,et al. Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype. , 1999, Mutation research.
[80] G. Sabbioni,et al. Haemoglobin adducts of aromatic amines: diamines and polyaromatic amines. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[81] S R Tannenbaum,et al. Gender- and smoking-related bladder cancer risk. , 2001, Journal of the National Cancer Institute.
[82] R. Hayes,et al. Mortality and incidence of bladder cancer in benzidine-exposed workers in China. , 1992, American journal of industrial medicine.
[83] D. Segerbäck,et al. Characterization of 4,4'-methylenebis(2-chloroaniline)--DNA adducts formed in vivo and in vitro. , 1992, Carcinogenesis.
[84] R. Hayes,et al. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[85] S. Tannenbaum,et al. Nonsmoking-related arylamine exposure and bladder cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[86] G. Talaska,et al. Carcinogen exposure and effect biomarkers. , 1999, Toxicology letters.
[87] A. Nersesyan. Re: Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. , 2001, Journal of the National Cancer Institute.
[88] M. Fenech,et al. The HUman MicroNucleus Project--An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. , 1999, Mutation research.
[89] H. K. Wilson,et al. A biological monitoring assessment of exposure to methylene dianiline in manufacturers and users. , 1994, Occupational and environmental medicine.
[90] J. S. Patel,et al. Benzidine and its acetylated metabolites in the urine of workers exposed to Direct Black 38. , 1988, Archives of environmental health.
[91] W. Albrecht,et al. Biomonitoring of aromatic amines III: Hemoglobin binding of benzidine and some benzidine congeners , 2005, Archives of Toxicology.
[92] E. Ward,et al. Assessing Exposure to 4, 4'-Methylene bis(2-chloroaniline) (MBOCA) in the Workplace , 1991 .
[93] G. Sabbioni,et al. Biomonitoring of arylamines and nitroarenes , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[94] R. Hayes,et al. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[95] H. Neumann,et al. Macromolecular adducts caused by environmental chemicals. , 1995, Clinical chemistry.
[96] D. Warburton,et al. Molecular and genetic damage from environmental tobacco smoke in young children. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[97] S. R. Babu,et al. Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites. pH stability and synthesis by human and dog liver. , 1996, Biochemical pharmacology.
[98] H. Behrendt,et al. Haemoglobin adducts from aromatic amines in children in relation to area of residence and exposure to environmental tobacco smoke , 2001, International archives of occupational and environmental health.
[99] Steven R. Tannenbaum,et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens , 1994, Nature.
[100] R. E. Harrell,et al. 2,6-Dimethylaniline--hemoglobin adducts from lidocaine in humans. , 1994, Carcinogenesis.
[101] J. Piotrowski. Quantitative estimation of aniline absorption through the skin in man. , 1957, Journal of hygiene, epidemiology, microbiology, and immunology.
[102] G. Curigliano,et al. 4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study. , 1998, Carcinogenesis.
[103] Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. , 2001, Journal of the National Cancer Institute.
[104] M. Butler,et al. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[105] H. Bartsch. Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. , 2000, Mutation research.